Last reviewed · How we verify

NCT06648330

Blood Lactate Level With Paraaortic Lymph Node Dissection

Completed Last updated 18 October 2024
What this trial tests

trial testing Paraaortic retroperitoneal lymph node dissection in Morbidity in 75 participants. Completed in 20 September 2024.

Timeline
1 September 2023
Primary endpoint
1 September 2024
20 September 2024

Quick facts

Lead sponsorDuygu Akyol
StatusCompleted
Study typeOBSERVATIONAL
Enrollment75
Start date1 September 2023
Primary completion1 September 2024
Estimated completion20 September 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Duygu Akyol

Who can join

18 and older, female only, with Morbidity or Gynaecologic Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was designed as a prospective observational study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Morbidity

Currently open trials in the same condition.

Other Duygu Akyol trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06648330.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing